ALLMedicine™ Cardiac Arrhythmias Center
Research & Reviews 1,996 results
https://clinicaltrials.gov/ct2/show/NCT05793398
Mar 31st, 2023 - Cardiac sarcoidosis (CS) is a complex disease that is characterized by the formation of inflammatory granulomas in the myocardium. The exact underlying pathophysiology of the disease is not yet fully understood, but it is believed to be related to...
https://clinicaltrials.gov/ct2/show/NCT05704426
Mar 30th, 2023 - The Impulse Dynamics Optimizer Device is a Food and Drug Administration (FDA) approved; commercially available device indicated for patients with heart failure with reduced ejection fraction (HFrEF). Many candidates of this device have a previousl...
https://clinicaltrials.gov/ct2/show/NCT00590200
Mar 27th, 2023 - The study is to commence on March 1st 2001 and is to be completed within 2-5 years. The targeted number of patients to be enrolled is 15,000. All patients undergoing cardiac catheterization or have had a heart catheterization within one year, comi...
https://clinicaltrials.gov/ct2/show/NCT05784753
Mar 27th, 2023 - The overall objectives for this study are to: (a) test the efficacy of virtual and in-person exercise interventions to promote long-term adherence to exercise; (b) determine a benchmark of exercise minutes that reaches a minimal clinically importa...
https://clinicaltrials.gov/ct2/show/NCT04750798
Mar 22nd, 2023 - The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) ...
Guidelines 4 results
https://doi.org/10.1016/j.hrthm.2020.05.004
Heart Rhythm; Nielsen JC, Lin YJ et. al.
Jun 20th, 2020 - European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118697
Heart Rhythm; Lakkireddy DR, Chung MK et. al.
Apr 5th, 2020 - Coronavirus disease 2019 (COVID-19) is a global pandemic that is wreaking havoc on the health and economy of much of human civilization. Electrophysiologists have been impacted personally and professionally by this global catastrophe. In this join...
https://doi.org/10.1253/circj.cj-66-0054
Circulation Journal : Official Journal of the Japanese Ci...
Nov 21st, 2012 - Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011).|2012| ,|therapy,methods,standards,methods,standards,standards,
https://doi.org/10.1161/CIRCULATIONAHA.109.192575
Circulation Poirier P, Alpert MA et. al.
Jun 17th, 2009 - Obesity is associated with comorbidities that may lead to disability and death. During the past 20 years, the number of individuals with a body mass index >30, 40, and 50 kg/m(2), respectively, has doubled, quadrupled, and quintupled in the United...
Drugs 257 results see all →
Clinicaltrials.gov 289 results
https://clinicaltrials.gov/ct2/show/NCT05793398
Mar 31st, 2023 - Cardiac sarcoidosis (CS) is a complex disease that is characterized by the formation of inflammatory granulomas in the myocardium. The exact underlying pathophysiology of the disease is not yet fully understood, but it is believed to be related to...
https://clinicaltrials.gov/ct2/show/NCT05704426
Mar 30th, 2023 - The Impulse Dynamics Optimizer Device is a Food and Drug Administration (FDA) approved; commercially available device indicated for patients with heart failure with reduced ejection fraction (HFrEF). Many candidates of this device have a previousl...
https://clinicaltrials.gov/ct2/show/NCT00590200
Mar 27th, 2023 - The study is to commence on March 1st 2001 and is to be completed within 2-5 years. The targeted number of patients to be enrolled is 15,000. All patients undergoing cardiac catheterization or have had a heart catheterization within one year, comi...
https://clinicaltrials.gov/ct2/show/NCT05784753
Mar 27th, 2023 - The overall objectives for this study are to: (a) test the efficacy of virtual and in-person exercise interventions to promote long-term adherence to exercise; (b) determine a benchmark of exercise minutes that reaches a minimal clinically importa...
https://clinicaltrials.gov/ct2/show/NCT04750798
Mar 22nd, 2023 - The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) ...
News 259 results
https://www.medpagetoday.com/neurology/sleepdisorders/103701
Mar 24th, 2023 - Pitolisant (Wakix) in children ages 6 years and up led to clinically meaningful improvements in narcolepsy symptoms in a phase III trial. Among 110 kids with narcolepsy with or without cataplexy, excessive daytime sleepiness and cataplexy scores i...
https://www.medpagetoday.com/geriatrics/generalgeriatrics/103157
Feb 17th, 2023 - Older patients prescribed an atypical antipsychotic for hospitalization-related delirium more often stayed on it past the recommended duration than if prescribed a typical antipsychotic, researchers reported. Among nearly 6,000 patients 65 and old...
https://www.mdedge.com/obgyn/article/259588/obstetrics/women-pursuing-assisted-reproductive-technology-prone-pregnancy
Nov 18th, 2022 - Key clinical point: Compared with women who conceive naturally, those who conceive through assisted reproductive technology (ART) have a higher risk for cardiovascular complications, including preeclampsia/eclampsia, heart failure, and cardiac arr.
https://www.onclive.com/view/novel-agents-replace-car-t-cell-therapy-in-later-line-relapsed-refractory-dlbcl
Nov 9th, 2022 - New treatments are emerging for patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in addition to chimeric antigen receptor (CAR) T-cell therapy, which has moved up into the second line. These advances come in the form of alte...
https://www.medpagetoday.com/cardiology/prevention/101165
Oct 11th, 2022 - Myocardial injury, not pre-existing cardiovascular disease, was a significant predictor of in-hospital death and cardiovascular events in critically ill patients with COVID-19. (Circulation: Cardiovascular Quality and Outcomes) Recurrent ischemic ...